Opinion

Video

Sequencing Therapies in the Third-Line and Beyond Setting for MCL

A panel of experts discuss how to sequence BTK inhibitors and CAR T-cell therapies in patients with MCL.

Related Videos
David C. Fisher, MD
Yair Lotan, MD, UT Southwestern Medical Center
Massimo Cristofanilli, MD, attending physician, NewYork-Presbyterian Hospital; professor, medicine, Weill Cornell Medical College, Cornell University
Farrukh Awan, MD
Minoo Battiwalla, MD, MS
Leo I. Gordon, MD
James K. McCluskey, MD, and Harry P. Erba, MD, PhD, discuss the role of genomic profiling in secondary acute myeloid leukemia.
James K. McCluskey, MD, and Harry P. Erba, MD, PhD, discuss the treatment goals in secondary acute myeloid leukemia.